Antithrombotic therapy in patients with established atherosclerotic coronary disease

Heart. 2023 Jun 14;109(13):1034-1043. doi: 10.1136/heartjnl-2022-321603.

Authors

Antonio Landi¹, Marco Valgimigli²

Affiliations

¹ Cardiovascular Department, Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale (EOC), Università della Svizzera Italiana, Lugano, Switzerland.
² Cardiovascular Department, Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale (EOC), Università della Svizzera Italiana, Lugano, Switzerland marco.valgimigli@eoc.ch.

PMID: 37142399
DOI: 10.1136/heartjnl-2022-321603

No abstract available

Keywords: acute coronary syndrome; coronary stenosis; pharmacology, clinical.

MeSH terms

Acute Coronary Syndrome* / drug therapy
Coronary Artery Disease* / complications
Coronary Artery Disease* / drug therapy
Drug Therapy, Combination
Fibrinolytic Agents / therapeutic use
Humans
Myocardial Infarction* / therapy
Platelet Aggregation Inhibitors / adverse effects

Substances

Fibrinolytic Agents
Platelet Aggregation Inhibitors